NASDAQ:NLTX

Neoleukin Therapeutics Earnings Date, Estimates, & History

$1.11

+0.03 (+2.78%)

(As of 05/19/2022 04:00 PM ET)

Add

Compare

Today's Range: $1.06
▼
$1.13
50-Day Range: $0.98
▼
$2.25
52-Week Range: $0.92
▼
$11.10

Volume: 143,364 shs
Average Volume: 268,651 shs
Market Capitalization: $47.18 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: 1.24

Upcoming Earnings Date: Aug. 4Estimated
Actual EPS (May. 9): -$0.28 Beat By $0.02
Consensus EPS (May. 9): -$0.30

Earnings Per Share Revenue

Neoleukin Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Neoleukin Therapeutics Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Neoleukin Therapeutics (NASDAQ:NLTX) Earnings Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2022	1	($0.29)	($0.29)	($0.29)
Q2 2022	1	($0.34)	($0.34)	($0.34)
Q3 2022	1	($0.40)	($0.40)	($0.40)
Q4 2022	1	($0.42)	($0.42)	($0.42)
FY 2022	4	($1.45)	($1.45)	($1.45)
Q1 2023	1	($0.44)	($0.44)	($0.44)
Q2 2023	1	($0.48)	($0.48)	($0.48)
Q3 2023	1	($0.53)	($0.53)	($0.53)
Q4 2023	1	($0.55)	($0.55)	($0.55)
FY 2023	4	($2.00)	($2.00)	($2.00)

NLTX Earnings Information

Neoleukin Therapeutics last issued its earnings data on May 9th, 2022. The reported ($0.28) EPS for the quarter, beating the consensus estimate of ($0.30) by $0.02. Neoleukin Therapeutics has generated ($1.11) earnings per share over the last year (($1.11) diluted earnings per share). Earnings for Neoleukin Therapeutics are expected to decrease in the coming year, from ($1.24) to ($1.30) per share. Neoleukin Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 4th, 2022 based off prior year's report dates.

Neoleukin Therapeutics (NASDAQ:NLTX) Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Actual Revenue
8/4/2022 (Estimated)
5/9/2022	3/31/2022	($0.30)	($0.28)	+$0.02
3/1/2022	Q4 2021	($0.30)	($0.28)	+$0.02	($0.28)
11/4/2021	9/30/2021	($0.28)	($0.28)		($0.28)
8/5/2021	6/30/2021	($0.26)	($0.27)	($0.01)	($0.27)
5/13/2021	3/31/2021	($0.23)	($0.27)	($0.04)	($0.27)
3/24/2021	12/31/2020	($0.21)	($0.24)	($0.03)	($0.24)
11/9/2020	Q3 2020	($0.21)	($0.18)	+$0.03	($0.32)
8/12/2020	6/30/2020	($0.21)	($0.20)	+$0.01	($0.20)
5/6/2020	3/31/2020	($0.23)	($0.18)	+$0.05	($0.18)
3/12/2020	12/31/2019	($0.37)	($0.22)	+$0.15	($0.23)

11/13/2019	Q3	($0.04)	($0.44)	($0.40)	$1.38
5/7/2019	Q1 2019		($0.09)	($0.09)	($0.09)
3/7/2019	Q4 2018		($0.20)	($0.20)	($0.20)
11/7/2018	Q3 2018		($0.64)	($0.64)	($0.64)
8/8/2018	Q2 2018		$0.12	+$0.12	$0.12	$25.00 million
5/8/2018	Q1 2018		($0.62)	($0.62)	($0.62)
3/12/2018	Q4 2017		($0.69)	($0.69)	($0.69)
11/8/2017	Q3 2017	($0.62)	($0.50)	+$0.12	($0.50)
8/8/2017	Q2 2017	($0.59)	($0.59)		($0.59)
5/9/2017	Q1 2017	($0.57)	($0.36)	+$0.21	($0.36)
3/9/2017	Q4 2016	($0.63)	($0.48)	+$0.15	($0.48)
11/9/2016	Q3 2016	($0.60)	($0.46)	+$0.14	($0.46)
8/4/2016	Q2 2016	($0.42)	($0.63)	($0.21)	($0.63)
5/10/2016	Q1 2016	($0.35)	($0.39)	($0.04)	($0.39)
3/14/2016	Q4 2015	($0.38)	($0.27)	+$0.11	($0.27)
11/10/2015	Q3 2015	($0.41)	($0.43)	($0.02)	($0.43)
8/6/2015	Q2 2015	($0.49)	($0.44)	+$0.05	($0.44)
5/12/2015	Q1 2015	($0.83)	($0.60)	+$0.23	($0.60)
3/16/2015	Q4 2014	($0.57)	($0.78)	($0.21)	($0.78)
11/4/2014	Q3 2014	($0.29)	($0.59)	($0.30)	($0.59)
8/11/2014	Q2 2014	($0.27)	($0.51)	($0.24)	($0.51)
5/13/2014	Q1 2014		($1.28)	($1.28)	($1.28)

(Earnings results data provided by Zacks Investment Research)

Neoleukin Therapeutics (NASDAQ:NLTX) Earnings Frequently Asked Questions

When is Neoleukin Therapeutics's earnings date?: Neoleukin Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 4th, 2022 based off last year's report dates. Learn more on NLTX's earnings history.
Did Neoleukin Therapeutics beat their earnings estimates last quarter?: In the previous quarter, Neoleukin Therapeutics (NASDAQ:NLTX) reported ($0.28) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.30) by $0.02. Learn more on analysts' earnings estimate vs. NLTX's actual earnings.

How much profit does Neoleukin Therapeutics generate each year?: Neoleukin Therapeutics (NASDAQ:NLTX) has a recorded net income of -$60.69 million. NLTX has generated -$1.11 earnings per share over the last four quarters.
What is Neoleukin Therapeutics's EPS forecast for next year?: Neoleukin Therapeutics's earnings are expected to decrease from ($1.24) per share to ($1.30) per share in the next year.

This page was last updated on 5/19/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources